國恩股份(002768.SZ):擬增持東寶生物股權比例至21.14% 將取得其控制權
格隆匯6月28日丨國恩股份(002768.SZ)公佈,公司於2021年6月25日與海南東寶實業有限公司(“東寶實業”)簽署了《股份轉讓協議》,以每股6元的價格,收購其持有的東寶生物6000萬股股份,股份轉讓總金額3.6億元。
此次協議轉讓前,東寶實業持有東寶生物138,823,422股股票,佔東寶生物總股本的23.35%,為東寶生物的控股股東;王軍直接持有東寶生物7,866,992股股票,佔東寶生物總股本的1.32%;王軍持有東寶實業93.89%的股權,通過東寶實業控制東寶生物23.35%的股份;王軍合計控制東寶生物24.67%的股份,為東寶生物實際控制人。
此次協議轉讓完成後,東寶實業持有東寶生物78,823,422股股票,佔東寶生物總股本的13.26%,不再是東寶生物的控股股東;王軍直接或間接控制東寶生物14.58%的股份,不再是東寶生物的實際控制人。
此次協議轉讓前,國恩股份持有東寶生物65,711,022股股票,佔東寶生物總股本的11.05%。此次協議轉讓完成後,國恩股份將持有東寶生物125,711,022股股票,佔東寶生物總股本的21.14%,成為東寶生物的控股股東。
此次交易符合公司發展戰略,此次交易完成後公司將取得包頭東寶生物技術股份有限公司的控制權,公司將充分利用優質產業資源,發揮與包頭東寶生物技術股份有限公司業務的協同效應,增強在生物醫藥及保健品業務領域的競爭優勢,增強可持續發展能力,符合公司的長遠發展目標和全體股東的整體利益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.